References
- Aitken CA, van Agt HME, Siebers AG, van Kemenade FJ, Niesters HGM, Melchers WJG, Vedder JEM, Schuurman R, van den Brule AJC, van der Linden HC, Hinrichs JWJ, Molijn A, Hoogduin KJ, van Hemel BM, de Kok IMCM. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study. BMC Med. 2019. 17: 228. https://doi.org/10.1186/s12916-019-1460-0
- Asciutto KC, Ernstson A, Forslund O, Borgfeldt C. Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples. J Clin Virol. 2018. 101: 69-73. https://doi.org/10.1016/j.jcv.2018.02.002
- Bernal S, Palomares JC, Artura A, Parra M, Cabezas JL, Robles A, Martin Mazuelos E. Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test. J Clin Virol. 2014. 61: 548-552. https://doi.org/10.1016/j.jcv.2014.10.001
- Cho HW, Ouh YT, Hong JH, Min KJ, So KA, Kim TJ, Paik ES, Lee JW, Moon JH, Lee JK. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay. J Virol Methods. 2019. 269: 77-82. https://doi.org/10.1016/j.jviromet.2019.04.012
- Colpani V, Soares Falcetta F, Bacelo Bidinotto A, Kops NL, Falavigna M, Serpa Hammes L, Schwartz Benzaken A, Kalume Maranhao AG, Domingues CMAS, Wendland EM. Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis. PLoS One. 2020. 15: e0229154. https://doi.org/10.1371/journal.pone.0229154
- Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006. 119: 1095-1101. https://doi.org/10.1002/ijc.21955
- Frati ER, Martinelli M, Fasoli E, Colzani D, Bianchi S, Binda S, Olivani P, Tanzi E. HPV Testing from Dried Urine Spots as a Tool for Cervical Cancer Screening in Low-Income Countries. Biomed Res Int. 2015. 2015: 283036.
- Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017. Cancer Res Treat. 2020. 52: 335-350. https://doi.org/10.4143/crt.2020.206
- Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. 2015. 136: 178-182. https://doi.org/10.1016/j.ygyno.2014.12.022
- Khunamornpong S, Settakorn J, Sukpan K, Lekawanvijit S, Katruang N, Siriaunkgul S. Comparison of Human Papillomavirus Detection in Urine and Cervical Samples Using High-Risk HPV DNA Testing in Northern Thailand. Obstet Gynecol Int. 2016. 2016: 6801491.
- Kim MA, Han GH, Kim JH, Seo K. Current Status of Human Papillomavirus Infection and Introduction of Vaccination to the National Immunization Program in Korea: an Overview. J Korean Med Sci. 2018. 33: e331. https://doi.org/10.3346/jkms.2018.33.e331
- Lim MC, Lee DH, Hwang SH, Hwang NR, Lee B, Shin HY, Jun JK, Yoo CW, Lee DO, Seo SS, Park SY, Joo J. Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples. J Virol Methods. 2017. 243: 74-79. https://doi.org/10.1016/j.jviromet.2017.01.020
- Nilyanimit P, Chansaenroj J, Karalak A, Laowahutanont P, Junyangdikul P, Poovorawan Y. Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay. PeerJ. 2017. 5: e3910. https://doi.org/10.7717/peerj.3910
- Pattyn J, Van Keer S, Biesmans S, Ieven M, Vanderborght C, Beyers K, Vankerckhoven V, Bruyndonckx R, Van Damme P, Vorsters A. Human papillomavirus detection in urine: Effect of a first-void urine collection device and timing of collection. J Virol Methods. 2019. 264: 23-30. https://doi.org/10.1016/j.jviromet.2018.11.008
- Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ; International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014. 383: 524-532. https://doi.org/10.1016/S0140-6736(13)62218-7
- Safaeian M, Solomon D, Castle PE. Cervical cancer prevention--cervical screening: science in evolution. Obstet Gynecol Clin North Am. 2007. 34: 739-760. https://doi.org/10.1016/j.ogc.2007.09.004
- Sultana F, Mullins R, English DR, Simpson JA, Drennan KT, Heley S, Wrede CD, Brotherton JM, Saville M, Gertig DM. Women's experience with home-based self-sampling for human papillomavirus testing. BMC Cancer. 2015. 15: 849. https://doi.org/10.1186/s12885-015-1804-x
- van den Akker-van Marle ME, van Ballegooijen M, van Oortmarssen GJ, Boer R, Habbema JD. Cost-effectiveness of cervical cancer screening: comparison of screening policies. J Natl Cancer Inst. 2002. 94: 193-204. https://doi.org/10.1093/jnci/94.3.193
- van Rosmalen J, de Kok IM, van Ballegooijen M. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing. BJOG. 2012. 119: 699-709. https://doi.org/10.1111/j.1471-0528.2011.03228.x
- Vergara N, Balanda M, Vidal D, Roldan F, S Martin H, Ramirez E. Detection and quantitation of human papillomavirus DNA in peripheral blood mononuclear cells from blood donors. J Med Virol. 2019. 91: 2009-2015. https://doi.org/10.1002/jmv.25551
- Virtanen A, Nieminen P, Niironen M, Luostarinen T, Anttila A. Self-sampling experiences among non-attendees to cervical screening. Gynecol Oncol. 2014. 135: 487-494. https://doi.org/10.1016/j.ygyno.2014.09.019
- Vorsters A, Micalessi I, Bilcke J, Ieven M, Bogers J, Van Damme P. Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis. 2012. 31: 627-640. https://doi.org/10.1007/s10096-011-1358-z
- Vorsters A, Van den Bergh J, Micalessi I, Biesmans S, Bogers J, Hens A, De Coster I, Ieven M, Van Damme P. Optimization of HPV DNA detection in urine by improving collection, storage, and extraction. Eur J Clin Microbiol Infect Dis. 2014. 33: 2005-2014. https://doi.org/10.1007/s10096-014-2147-2
- World Health Organization 2020. Human Papillomavirus (HPV) and Cervical Cancer 2020.